Ascendis Pharma A/S
USPTO PatentsView assignee record - 42 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Ascendis ranks #7,661 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 12 technology areas.
- #7,661
- of 49,997 US assignees by volume
- Top 12%
- by Innovation Score (51.2/100)
- 19.5
- avg claims per patent
- +69%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R7661 · Foreign Corporation #7,661 · 42 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 42 grants
- UPPER-Q #7,661/49,997
- PHOTO-FINISH AGC Automotive…
- CPC-FOCUS A61K · 12 areas
- INNOV-PAR 51.2/100
- CLAIMS-RICH 19.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +69% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: AGC Automotive Americas R&D, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ascendis’s 51.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ascendis
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ascendis Pharma A/S · this assignee
Ascendis Pharma A/S · this assignee
51 score
- Chime Financial · near
Chime Financial · near
51 score
- Technical University… · near
Technical University… · near
51 score
- Transocean Sedco… · near
Transocean Sedco… · near
51 score
- Yamaguchi University · near
Yamaguchi University · near
51 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ascendis's Innovation Score is 51.2/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ascendis?
Each dot is one of Ascendis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ascendis’s own 19.5 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ascendis's grants concentrate
Ascendis Pharma A/S is a focused PatentsView assignee: 12 CPC subclasses with 52.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (6 grants) versus a trough of 1 in 2016. By volume, Ascendis sits between A.M. Surgical, Inc. and Armaments Research Company, Inc..
Ascendis's three-year grant acceleration
Ascendis Pharma A/S shows 15 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Ascendis's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- A M Surgical
A.M. Surgical, Inc.
42 patents
- AGC Automotive Am…
AGC Automotive Americas R&D, Inc.
42 patents
- Allnex Netherland…
Allnex Netherlands BV
42 patents
- ARB
ARB Corporation Limited
42 patents
- Allergan Industri…
Allergan Industrie, SAS
42 patents
- Amtech Systems
Amtech Systems, LLC
42 patents
- Arity Internation…
Arity International Limited
42 patents
- Armaments Research
Armaments Research Company, Inc.
42 patents
- Ascendis Pharma A… ◀
Ascendis Pharma A/S
42 patents
What this shows Ascendis holds 42 patents at rank #7,657, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ascendis
By rank, the assignees closest to #7,657 in granted patent volume.
- A.M. Surgical, Inc. #7,653 · 42 patents
- AGC Automotive Americas R&D, Inc. #7,654 · 42 patents
- Allnex Netherlands BV #7,655 · 42 patents
- ARB Corporation Limited #7,656 · 42 patents
- Allergan Industrie, SAS #7,658 · 42 patents
- Amtech Systems, LLC #7,659 · 42 patents
- Arity International Limited #7,660 · 42 patents
- Armaments Research Company, Inc. #7,661 · 42 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Ascendis's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Ascendis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Ascendis ranks #1,019 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (51 here).
Ascendis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 9.5% |
| 2016 | 1 | 2.4% |
| 2017 | 3 | 7.1% |
| 2018 | 5 | 11.9% |
| 2020 | 3 | 7.1% |
| 2021 | 4 | 9.5% |
| 2022 | 5 | 11.9% |
| 2023 | 6 | 14.3% |
| 2024 | 4 | 9.5% |
| 2025partial year | 7 | 16.7% |
Which technologies does Ascendis Pharma A/S patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ascendis Pharma A/S's patent record in context - here's where to go next.
- Ascendis Pharma A/S's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 52.4% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #7,661 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ascendis Pharma A/S against A.M. Surgical, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 51.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.